T.FIRE
|
MMs will buy up the safer plays first, but even with less visibility FIRE...
|
V.CYX.H
|
I'm sure we'd all love to see .27 at the open but there's...
|
DDBXF
|
I see this popping again at open, if it goes high enough I may take some...
|
V.NSP.H
|
Dog??? If you're calling NSP a dog then you've obviously been here...
|
V.NSP.H
|
This NR pretty much checks every box on the 'must have' list. ...
|
V.NSP.H
|
I'd rather invest in a company with a 100% stake in real revenue (like...
|
V.NSP.H
|
20 years experience in the consumables industry, Mason has the kind of back...
|
V.NSP.H
|
Haha, oops, was thinking about Cyx, hope to see Nsp close over .3 for the...
|
V.NSP.H
|
Kushman, great post. I've owned NSP since before they got into...
|
INM
|
That was a great segment on BNN. The CEO didn't over promise but...
|
INM
|
Yes, that would be illegal, but I was only suggesting that investors are...
|
INM
|
Just opinion but I think investment houses are accumulating in...
|
INM
|
Smart to time the nr immediately after the pp. positive nr, no setbacks...
|
INM
|
Oops that's phase 1 clinical trials and I believe that's expected in...
|
INM
|
Why, just to boost the stock price? The float is only 53million shares...
|
INM
|
This nano-particle delivery system could be extremely profitable for...
|
INM
|
This guy is either confused or is trying to mislead InMed investors. ...
|
INM
|
Don't know where you've been looking, this is a link InMeds website...
|
INM
|
I see this exploding when clinical trails are announced as a worst case...
|
INM
|
Just one milestone that legitimizes InMed as a bobafide pharmaceutical...
|